RFC
BRLI

Russell Frank Company’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Russell Frank Company’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-16,638
Closed -$687K – 3142
2015
Q2 		$687K Sell
16,638
-79
-0.5% -$2.83K ﹤0.01% 2481
2015
Q1 		$589K Buy
16,717
+1,210
+8% +$40.9K ﹤0.01% 2359
2014
Q4 		$502K Hold
15,507
– – ﹤0.01% 2395
2014
Q3 		$435K Buy
15,507
+4,107
+36% +$125K ﹤0.01% 2377
2014
Q2 		$361K Buy
11,400
+2,000
+21% +$55.2K ﹤0.01% 2424
2014
Q1 		$260K Sell
9,400
-24,899
-73% -$652K ﹤0.01% 2524
2013
Q4 		$919K Sell
34,299
-245,317
-88% -$7.56M ﹤0.01% 2107
2013
Q3 		$8.35M Sell
279,616
-140,981
-34% -$3.92M 0.01% 1003
2013
Q2 		$12.1M Buy
+420,597
New +$11.6M 0.02% 768

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Russell Frank Company's BRLI Position: Q3 2015 in Review

Russell Frank Company sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 16,638 shares — an estimated $687K sold.

Russell Frank Company first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $12.1M in Q2 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Russell Frank Company reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Russell Frank Company sold 16,638 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $687K.
  • Russell Frank Company first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Russell Frank Company's BIO-REFERENCE LABS INC-NEW- position peaked at $12.1M in Q2 2013.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Russell Frank Company's 13F filing for Q3 2015, filed 23 Oct 2015.